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Resumo 
Piranose 2-oxidases (P2Ox) são flavoproteínas que catalisam a oxidação do carbono 2 de 
aldopiranoses, com redução concomitante de O2 a H2O2 e, que apresentam, um grande interesse 
biotecnológico. Recentemente, foi caracterizada pela primeira vez, uma P2Ox bacteriana, AsP2Ox de 
Arthrobacter siccitolerans. As bactérias apresentam maior rapidez de crescimento, em comparação 
com os fungos, e existe grande disponibilidade de ferramentas de biologia molecular em sistemas 
bacterianos. No entanto, verificou-se que a eficiência catalítica de AsP2Ox era seis-ordens de 
magnitude inferior à exibida pelas enzimas fúngicas. Neste trabalho, a evolução dirigida foi utilizada na 
engenharia da enzima AsP2Ox, para melhoramento da sua eficiência catalítica. Otimizaram-se 
protocolos de mutagénese, seleção e crescimento de células hospedeiras, lise celular e ensaios 
enzimáticos. A aplicação de uma estratégia validada de mutagénese e “screening” permitiu a seleção 
de um variante, 2C9, com atividade enzimática superior à observada na enzima nativa, a partir de uma 
biblioteca de 25 000 clones. Após purificação, verificou-se que o seu nível de produção era 6 vezes 
mais baixo relativamente à enzima nativa e mostrava ser inativado pela luz. Este variante contém duas 
mutações não sinónimas (A35T e F300V) e uma sinónima (Q343Q). Com o objetivo de avaliar o efeito 
das mutações nas propriedades do variante, foram construídos os mutantes “single” (A35T e F300V) e 
o mutante duplo 2C9* (A35T/F300V), sem a mutação sinónima. Concluiu-se que a mutação Q343Q era 
a única responsável pela foto-inativação da enzima, e, em conjunto com a mutação F300V, contribuía 
para os níveis de produção mais baixos. Verificou-se ainda que a mutação A35T era neutra, mas 
indispensável para, combinada com a mutação F300V, numa interação epistática, resultar numa 
eficiência catalítica 3 vezes superior no variante 2C9*, relativamente à enzima nativa. Assim sendo, o 
mutante 2C9* foi selecionado como parente para uma segunda geração de evolução dirigida.  
 
Palavras-chave: flavoproteínas, enzimas formadoras de peróxido, evolução dirigida, eficiência 
catalítica, biosensores 
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Abstract 
Pyranose 2-oxidases (P2Ox) are flavoproteins that catalyze the oxidation of several aldopyranoses to 
yield the corresponding 2-keto-aldoses with concomitant reduction of O2 to H2O2 and are enzymes that 
show many biotechnological applications. Recently, a bacterial P2Ox from Arthrobacter siccitolerans 
(AsP2Ox) was characterized for the first time since bacteria grow faster as compared to fungi and have 
well-established genetic and molecular biological tools allowing for higher enzyme production yields. 
Directed evolution has proven to be a powerful approach to improve enzyme efficiency and robustness 
required for biotechnological applications. Therefore, in this work the optimization and validation of 
critical steps of directed evolution was performed, namely mutagenesis protocols, cell growth, lysis and 
high-throughput enzymatic assays. One round of evolution through error prone PCR was performed and 
a total of 25 000 clones were screened to find variants with improved activity for D-glucose and dioxygen. 
One hit variant, 2C9, was identified, showing higher activity than wild-type and containing two non-
synonymous (A35T and F300V) and one synonymous mutation (Q343Q). The variant enzyme was 
produced at a larger scale, purified and characterized. It was observed that 2C9 was produced at 6-fold 
lower yields as compared to wild-type and showed photo-inactivation behaviour. Therefore single 
mutants (A35T and F300V) and double 2C9* without the silent mutation (A35T/F300V) were constructed 
and characterized to unveil the role of mutations from the catalytic and structural viewpoints. The 
introduction of the synonymous mutation Q343Q resulted in the photo-inactivation of the enzyme and 
was co-responsible, along with the F300V mutation, to the variant lower production yields. Mutation 
A35T was neutral but in combination with the functional F300V mutation, an epistatic effect became 
evident, resulting in the 3-fold higher catalytic efficiency exhibited by 2C9* as compared with the wild-
type enzyme. Therefore, 2C9* was selected as a parent for the second generation of directed evolution. 
 
Keywords: flavoproteins, hydrogen peroxide forming enzymes, directed evolution, catalytic efficiency, 
biosensors   
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1. Introduction 
1.1. Fungal pyranose oxidases: General properties and catalysis 
Pyranose 2-oxidases (P2Ox, pyranose: oxygen 2-oxidoreductase; EC 1.1.3.10; synonym, glucose 2-
oxidase) belong to the glucose-methanol-choline (GMC) oxidoreductase superfamily of enzymes1. This 
family includes enzymes such as glucose oxidase, choline oxidase, cholesterol oxidase, cellobiose 
dehydrogenase, aryl-alcohol oxidase, pyridoxine 4-oxidase, among others1. P2Oxs are flavin adenine 
dinucleotide (FAD)-dependent enzymes, exhibiting the typical UV–Visible spectrum of the FAD cofactor 
with absorption maxima at 360 and 455 nm2. 
P2Oxs catalyze the regiospecific oxidation of sugar molecules at an alcohol moiety (-CH-OH) to the 
corresponding aldehyde with concomitant reduction of molecular oxygen to hydrogen peroxide3,4. 
Several aldopyranoses and disaccharides such as D-glucose, D-galactose, D-mannose, D-arabinose, 
D-fructose, L-sorbose, D-xylose, D-fucose, maltose and trehalose are oxidized at the C2 position to 
yield the corresponding 2-keto-aldoses5,6. These enzymes can also use quinones as electron acceptors  
in replacement to O2 and show a higher efficiency for substituted benzoquinones, structural analogues 
of benzoquinone (e.g. DCPIP), metal ions such as ferricyanide and ferrocenium, and radicals (e.g. the 
cation radical ABTS+)7. The specific activity of P2Ox for the different sugar substrates varies 
considerably, but D-glucose has been identified as the favourite substrate4. Oxidation at the C3 position, 
as a side reaction,  was also observed with 2-deoxy-D-glucose, 2-keto-D-glucose and methyl β-D-
glucosides, indicating that when the C2 hydroxyl group is compromised, P2Oxs have the ability to 
oxidize sugar substrates at a different position, demonstrating an alternative regioselectivity8,9,10. 
The first P2Ox enzyme was isolated from the fungus Polyporus obtusus, followed by its characterization 
in several other P2Oxs, mainly from wood-degrading, white- and brown-rot, basidiomycetes11. In these 
microorganisms, P2Oxs are located in the hyphal periplasmic space and are released to the extracellular 
space in the later stages of the fungal cycle development11. Fungal enzymes have D-glucose, D-
galactose and D-xylose as preferred substrates most likely due to their abundance in lignocellulose 
material originated from wood rot. Their physiological role has been associated with the generation of 
H2O2 that is an essential substrate for lignin-degrading peroxidases5,12. Furthermore, it was shown that 
in some species of white-rot fungi, P2Oxs are involved in secondary metabolic pathways that lead to 
the production of the antibiotic cortalcerone, protecting the microorganism from bacterial attack5. As 
quinones act as alternative electron acceptors to O2, it has been claimed that P2Oxs can also get 
involved in the reduction of quinones during the process of ligninolysis11. 
The reaction catalyzed by P2Oxs can be divided in two half-reactions: a reductive half-reaction, where 
the transfer of two electrons from a sugar substrate to the oxidized FAD occurs leading to the formation 
of a 2-keto-sugar and reduced FADH2, and an oxidative half reaction, where two electrons from the 
reduced FADH2, are transferred to molecular oxygen, with concomitant formation of H2O23,13 (figure 1.1). 
The first evidence for the formation of an intermediate in a flavoprotein oxidase was detected in P2Ox, 
the C-4a-hydroperoxyflavin intermediate, observed during the oxidative half reaction, when O2 acts as 
electron acceptor11. Considering that the 2-keto-sugar product is thought to be released before oxygen 
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reduction, the mechanism of the reaction catalyzed by P2Oxs was classified as a ping-pong bi-bi type, 
characteristic of flavoprotein oxidoreductases1. Typically, P2Oxs activity is measured through H2O2 
production in a coupled spectrophotometric assay using a commercial peroxidase and a chromogen 
substrate, or using an O2 electrode by measuring the rate of O2 consumption2.  
 
 
 
 
 
 
 
 
 
Figure 1.1 Schematic reaction catalyzed by P2Ox: first the transfer of two electrons from D-glucose to the FAD 
cofactor occurs followed by O2 reduction resulting in the formation of 2-keto-D-glucose and H2O2. 
 
1.2. Pyranose 2-oxidase from Arthrobacter siccitolerans (AsP2Ox)  
P2Oxs from fungal origin have been extensively studied and characterized. Consequently, in our lab it 
was settled as an objective to isolate and characterize a P2Ox enzyme from bacterial origin: 
Arthrobacter siccitolerans (AsP2Ox). In these microorganisms, recombinant proteins are easier and 
cheaper to produce,  since they reach higher cell densities in shorter periods of time as compared with 
fungi, and there are plenty of genetic and molecular tools available14. A bioinformatics analysis was 
performed using Basic Local Alignment Search Tool (BLAST) in all bacterial genomes available using 
as template the sequence of the fungal P2Ox from Trametes multicolor. The top 100 Blast sequence 
hits from bacterial genomes showed an identity between 24 and 39% to the template and 85 out of 100 
sequences identified belong to members of the Actinobacteria3 phyla, one of the most dominant in the 
bacteria domain, present in varied ecosystems such as alkaline saline soils, marine sponges, deep sea 
sediments, hot springs, gut and medicinal plants. Actinobacteria displays an important biological role in 
biogeochemical cycles, bioremediation, bioweathering and plant growth promotion15,16. Furthermore, 
they produce a large number of pharmaceutically bioactive compounds such as antibiotics, antitumor 
agents, anti-inflammatory compounds, enzyme inhibitors and a wide variety of industrial and clinically 
important enzymes16. The most represented putative P2Ox sequences (62%) are from species of the 
Streptomyces (14), Arthrobacter (17) and Microbacterium (25) genera. The A. siccitolerans genome 
revealed an ORF encoding a 519 amino acid polypeptide that showed 26% homology with the P2Ox 
template sharing 13 of the 15 strictly conserved residues present in GMC family in the: (i) FAD-binding 
domain, (ii) flavin attachment loop and (iii) substrate binding domain that was putatively assigned as a 
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pyranose 2-oxidase (AsP2Ox)3,17,18. The gene was cloned and the enzyme was overproduced in 
Escherichia coli. After purification, AsP2Ox showed a yellow colour and the typical flavoprotein visible 
absorption spectrum with two peaks at 390 and 460 nm, with a flavin-protein molar ratio of approximately 
1:13. Unlike most known fungal enzymes, in AsP2Ox, the FAD molecule is not covalently bonded to the 
protein and the enzyme is monomeric with a molecular mass of 64 kDa, while fungal counterparts are 
tetrameric enzymes. AsP2Ox exhibited an optimal temperature at 37⁰C, an optimum pH of 6.5 and 
oxidizes D-glucose at the highest efficiency, using additionally D-galactose, D-xylose, L-arabinose and 
D-ribose as electron donors, coupling their oxidation to the reduction of both dioxygen and 1,4-
benzoquinone (1,4-BQ), the preferred electron acceptor3. It shows a Km value 2-orders of magnitude 
higher and a kcat between 2 to 3 orders of magnitude lower for D-glucose and dioxygen when compared 
with P2Ox characterized from fungal origins resulting in a 6 to 7-orders of magnitude reduced catalytic 
efficiency (kcat/Km)11,12.  
1.3. Structural characterization of P2Ox 
Only three crystal structures were reported to date for P2Oxs from fungal origin: T. multicolor19, 
Peniophora sp.20 and Phanerochaete chrysosporium10. All structures are homotetrameric proteins, in 
some cases glycosylated, constituted by a dimer of dimers with molecular masses in the range of 280-
320 kDa2 (figure 1.2-A). FAD is covalently linked to the monomers by a histidyl linkage21. As shown in 
figure 1.2-B, each subunit of the homotetramer can be seen as a central, peanut-shaped elongated 
‘body’ with an ‘arm’ projected to the outside that is responsible for the contact with neighbouring subunits 
and a ‘head’ (αββα motif) that possibly acts as a immobilizer of the enzyme in the fungal cell-wall19. The 
FAD-subdomain presents a Rossman fold (βαβ mononucleotide-binding motif) and the substrate-
binding subdomain is composed by a central six-stranded β sheet packed between the active site and 
three α helices19. 
The substrate has to pass through a large, internal cavity that contains water, before accessing the 
active site of each subunit19. The amino acid residues with a role in the catalytic reaction of T. multicolor, 
and that are conserved in other fungal P2Oxs, are His548, Asn593, Gln448, His450 and Val546. With 
the support of Asn593, the His548 amino acid residue most probably acts as a base and deprotonates 
the substrate at the 2-OH group with a subsequent hydride transference to the flavin N(5) atom19. In 
AsP2Ox, the main catalytic amino acid residues (His440, Asn484 and Gln340) are conserved, however 
catalytic residue His450 in T. multicolor P2Ox appears as Met342 in AsP2Ox and Val546 in T. multicolor 
P2Ox as Ser438 in AsP2Ox, which can have implications in the catalytic reaction.  
The active site of T. multicolor P2Ox is gated by a dynamic, highly conserved loop (residues 450-461) 
that presents several residues that efficiently bind both electron-donor (sugar) and electron-acceptor 
substrates (oxygen or quinone derivates) and are therefore determinant for the substrate binding and 
catalysis19,22. Through the analyses of two P2Ox crystal structures, one in a sugar free form (acetate-
bonded, figure 1.2-C) in native P2Ox and the other in a sugar-bonded form (2-keto-D-glucose-bonded, 
figure 1.2-D) in the mutant H167A enzyme, it is possible to observe at least two loop conformations that 
were assigned to the two half-reactions of the enzyme19.  
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Figure 1.2 Crystal structure of P2Ox from T. multicolor19. (A) Homotetramer structure and subunit assembly. (B) 
Structure of P2Ox subunit. In purple is represented the oligomerization arm and in beige the head domain. The 
Rossman domain is represented in pink and the substrate binding domain in brown. The FAD cofactor is shown as 
a yellow stick representation. Subunit structure with the substrate-recognition loop represented in orange in a closed 
(C) and open (D) conformation. The gating segment (Phe454, Ser455 and Tyr456) is shown as an orange and FAD 
cofactor as a yellow stick representation in (C) and (D). (A), (B), (C) structures corresponds to PDB code 1TT0 and 
(D) to PDB code 2IGO. 
 
When the P2Ox enzyme is in complex with small ligands (e.g. acetate), the loop is in a fully closed 
conformation with the active site less accessible, providing a more hydrophobic environment, 
appropriate for the reaction of the reduced enzyme with electron-acceptors such as dioxygen, and for 
the accommodation and stabilization of the C(4a)-hydroperoxyflavin intermediate, during the oxidative 
half-reaction (figure 1.2-C)19,23,24. The structure of the H167A mutant shows that the loop is in an open 
conformation, suitable to accommodate the sugar substrates in the reductive half-reaction (figure 1.2-
D)9,22. The observed conformational transition is apparently due to the 454FSY456 motif in the substrate-
recognition loop, which, in the oxidative half-reaction, comes closer to the active site, blocking access 
of larger substrates, such as sugars22. It was demonstrated that these residues are intolerant to 
substitution, but in AsP2Ox only the serine residue is conserved, 346ASP348, with structural and functional 
B A 
C D 
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consequences that are yet to be understood. Among members of the GMC family of enzymes with three-
dimensional structures available, only P2Oxs present a covalently bonded FAD which is recognized to 
facilitate the substrate oxidation and help to increase the redox potential of the enzyme19,25. The 
sequence motif associated with flavinylation of the P2Ox is 165STHW16819 and in AsP2Ox, the 
corresponding motif has two alanine residues that are not conserved: 125AAHW128. As previously 
mentioned, AsP2Ox does not present a covalently bonded FAD cofactor, which can relate to the 
alteration of this motif despite its absence apparently not affects the redox potential of the enzyme (-50 
mV) that is slightly higher that the fungal counterpart with known redox potential (-105 mV)1. 
1.4. Applications of P2Oxs 
In the last decades there has been an increased interest in the use of P2Oxs as a biocatalyst for the 
construction of biosensors or biofuel cells by biotechnological industries. P2Ox has the potential to 
substitute the widely used glucose oxidase (GOx) as an analytical reagent in diagnostic kits. The main 
advantages of P2Ox in relation to GOx are the high range of substrates and the lack of an anomer 
preference (GOx only oxidizes the β-anomer of D-glucose), which leads to an improvement in the 
response time of the reaction2,26.  
P2Oxs can be used in biosensors and biofuel cells through the utilization of redox mediators such as 
osmium, redox polymers, ferrocenes or benzoquinone that have the ability of transfer electrons from the 
enzyme to the electrode11. The number of diabetic patients is increasing nowadays and it is possible to 
employ P2Oxs in biosensors constructed for the determination of 1,5-anhydro-D-glucitol (1,5-AG), a 
natural analogue of D-glucose present in human cerebrospinal fluid and in serum2,27. It is known that a 
decrease of this compound in serum is related with hyperglycemia or renal dysfunction and therefore 
P2Ox can be used as a marker of glycemic control in diabetes mellitus2,28. A commercial biosensor with 
P2Ox (GlycoMark) based at H2O2 measurement is currently in the market and other detection methods 
are being tested using, for example, electrochemical impedance spectroscopy29,27. Recently, P2Ox was 
immobilized and stabilized in carbon nanotubes, to improve the glucose sensitivity of biosensors and to 
increase the power density of biofuel cells. When tested in the determination of sugars in soft drinks, 
P2Ox showed a higher sensitivity compared to the GOx enzyme30,31. 
Another potential application of P2Ox is in carbohydrate chemistry for the development of efficient routes 
that convert bulk carbohydrates into more valuable products and materials32,33. This application relies 
on the large number of products with industrial interest that can be produced using 2-keto-D-glucose as 
intermediate: D-fructose, mannitol, 2,3-di-keto-4-deoxy-D-glucose, that are part of the pathway for the 
production of rare sugars, fine chemicals and drugs32. One example of a drug produced from 2-keto-D-
glucose is the β-pyrone antibiotic cortalcerone34. This antibiotic is rare in nature and can be produced 
using two enzymatic steps: D-glucose is first oxidized to 2-keto-D-glucose by P2Ox which is then 
dehydrated to cortalcerone by pyranosone dehydratase35,36. In addition to 2-keto-D-glucose, other keto-
sugars can be produced using P2Ox, including 2-keto-D-galactose, a precursor of the rare sugar D-
tagatose, a low-calorie and noncariogenic sweetener, and 2-deoxy-3-keto-D-glucose, a precursor for 
the production of vitamins B1 and B632,37. 
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Anaerobic conditions are sometimes extremely important for electroanalytical procedures but they are 
often difficult to achieve38. Therefore, P2Ox can be used as oxygen scavenger to create anaerobic 
conditions and consequently increase the compound lifetime through the prevention of oxygen-based 
reactions39. With this objective, P2Ox was tested in an oxygen removal system and it was demonstrated 
that this enzyme is as good as the common scavenging systems but with the advantages of allowing for 
a long-term pH stability and higher versatility in buffer conditions in terms of ionic strength39,38.  
1.5. Protein engineering  
The majority of organisms’ native enzymes are not suitable for application in cost-effective industrial 
bioprocesses due to their poor stability, relatively low reaction rates, product inhibition or limited 
substrate conversion yields40. Protein engineering allows to design enzymes to new or desirable tailor-
made properties, appropriate for industrial applications, within short time frames and with the help of a 
range of strategies that goes from rational computational design to entirely random mutagenic libraries41. 
It is based on the use of recombinant DNA to change protein amino acid sequences42 and there are 
three main approaches that can be followed for enzyme engineering: rational design, semi-rational 
design and directed evolution. 
1.5.1 Methods for introducing mutations in a target gene 
The process of rational design is the most classical method and deals with preconceived amino acid 
sequence changes into a target gene through the use of a site-directed mutagenesis (SDM)42. This 
approach is very useful when the structure of a protein is well known, either from a model or a crystal 
structure, and when it is possible to identify a region of the protein critical for its catalysis or stability43. 
Rational mutagenesis is thus useful to test hypotheses about the structural and functional roles of 
specific amino acid residues in an enzyme44. The ‘whole plasmid single round PCR’ from Stratagene 
(‘QuickChange SDM kit’) is the most commonly approach used to replace specific amino acids into a 
target gene. In this strategy, two oligonucleotide primers containing the desired mutation(s) to be 
replaced are constructed (complementary to the opposite strands of a double-stranded DNA plasmid 
template) and their extension occurs in a PCR reaction through the action of DNA polymerases44. Both 
strands of the template are replicated without the displacement of the primers and a mutated plasmid is 
obtained with breaks that do not overlap42. Afterwards, a selective digestion is performed for the 
elimination of methylated, non-mutated parent DNA template, and a circular, nicked vector containing 
the mutant gene is obtained and transformed into competent cells where the nicked vector is repaired 
by the cell machinery44. Finally, mutant proteins are overproduced, purified and characterised, allowing 
to assess their functional performance45,46. 
The main advantage of directed evolution, a ‘Darwinian selection’ that mimics the natural evolution, is 
the non-requirement of previous knowledge on structure-function relationships47. It relies only on the 
principle of mutation and selection, and in a first step diversity is created in the parent gene using random 
mutagenesis or recombination through DNA shuffling, to generate a library of mutant variants46,48. In a 
second step, appropriated methods are used to identify library members that present improved 
phenotypes through a strategy of selection or screening49. The improved variant is used as parent for 
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the next generation of mutagenesis and screening, and iterative rounds of evolution follow until the 
desired properties are reached46 (figure 1.3). Directed evolution has successfully been used to improve 
characteristics such as substrate specificity, organic solvent resistance, thermostability and up- or down-
shifted optimum pH of a large number of enzymes50. Random mutagenesis is commonly achieved using 
E. coli mutator strains, chemical mutagenesis or error-prone polymerase chain reaction (epPCR) for the 
construction of libraries of enzyme variants47,49. The most popular method is epPCR which is performed 
under conditions that conduct to a low fidelity performance of DNA polymerases during DNA synthesis. 
Usually, a low mutation rate is preferred to ensure a high probability to find beneficial mutations, since 
most random mutations are either neutral or deleterious46. With the aim of controlling the rate of 
mutation, it is possible to change (1) the number of PCR cycles, (2) the concentration of DNA 
polymerase, (3) the concentration of MgCl2, (4) the concentration of dNTPs or the use of mutagenic 
dNTP analogues and, (5) the concentration of MnCl2 in the reaction mixture51,52. The drawbacks of this 
strategy are the high tendency of A → G and T → C nucleotide transitions which lead to a large GC 
content and the inherent bias introduced by polymerases that limits the type of mutations that can be 
achieved46,52. These inconvenient can be reduced through the use of unbalanced dNTP concentrations 
and appropriate mixtures of DNA polymerases49. The beneficial mutations achieved by this strategy can 
be subsequently combined through recombination, namely DNA shuffling53. Recombination allows the 
mixture of homologous genes encoding for variants of the same gene or of genes coding for structurally 
similar proteins of different origin40,47. In DNA shuffling, selected genes suffer a controlled fragmentation 
(~50 to 150 base pairs) with DNaseI and are subsequently combined in an in vitro PCR reaction without 
the need of adding primers since the fragments themselves align and cross-prime to each other42. 
Finally, the small amount of full-length gene present in the reassembly reaction is amplified through the 
use of appropriate flanking primers in a standard PCR reaction46. Among the resulting genes, the most 
promising ones are selected by screening and isolated54. The advantages of this approach is the 
possibility to accumulate beneficial mutations that can be additive and to eliminate deleterious 
mutations, which is not possible through the use of non-recombinative strategies as epPCR55. 
 
 
 
 
Figure 1.3 Overview of directed evolution of proteins with all steps needed to achieve a desired property: generation 
of diversity, the choice of a good method of screening/selection, identification of a variant with an improved property 
and repetition of the cycle until a variant with the desired property is found. 
 
Semi-rational design is a strategy based on the previous knowledge of structure-function relationships 
i.e. of amino acid residues that are important for catalysis, and is useful when a dramatic alteration of 
the specificity or regioselectivity of the enzyme is required47. Through site-saturation mutagenesis 
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(SSM), it is possible to substitute an amino acid residue for all the other nineteen amino acids available 
at once. Synthetic oligonucleotides with a randomized codon flanked by wild-type sequences 
(mutagenic primers) are used to produce every possible amino acid single mutant (‘smart libraries’)40. 
Due to technical similarities, all methodologies used for SDM can also be applied in SSM with 
differences in the nature of mutagenic primers; in SSM these are degenerated, i.e. a mixture of 
oligonucleotides that are identical to the parental DNA (allowing the annealing) except for specific 
targeted positions that permit creating the diversity of amplified products56. After a faster and simpler 
screening, since a smaller library of variants is generated, as compared with random mutagenesis, the 
best amino acid residue for a given position is chosen considering the property of interest56,57,58. There 
is also the possibility to randomize several codons simultaneously40.  
In addition to above mentioned traditional methods of protein engineering, there is a tool that is 
becoming increasingly important: computational protein design that is based on the combination of a 
force field and a search algorithm to identify the amino acid sequence most compatible with a three-
dimensional conformation of a given protein42. The algorithm has the capability of change at selected 
positions, the original amino acid to all other nineteen possible amino acids that result in new 
conformations with different energies42. Finally, the conformations that present lower energies are the 
most favourable and are retained. 
1.5.2 Methods of analysis and isolation of variants from a library of mutants 
In directed evolution, selection/screening is the most crucial and challenging step and it needs to be 
sufficiently sensitive and fast enough to find improved variants from large mutant libraries. These can 
generally be divided in to selection and screening or in vivo versus in vitro methodologies. The 
differences between these strategies are based on how the genotype (genetic information encoding for 
a protein) and the phenotype (the function of the translated protein) are linked.  
In the selection strategies there is no need to analyse each library mutant individually due to the 
presence of a direct link between cell survival or growth and the improved or acquired enzyme function49. 
Selection methods directly eliminate undesired enzyme variants without the requirement of special 
instruments49 and their advantages are the possibility of analysing a much larger library of mutants in a 
reduced time scale50. The main disadvantages of the in vivo systems relate to the fact that some proteins 
are toxic for the cells and thus only cellular-harmless enzymes or enzymes that synthetize essential 
nutrients for cell growth can be engineered, and to the limited genetic diversity that is commonly present 
due to low transformation efficiencies40,48.  
In screening methods, a gene is associated with a certain phenotype (enzymatic activity for a certain 
substrate, for example) and each mutant protein is evaluated individually for the desired property50. The 
most simple screening is performed in agar plates after growing the library of mutants in the presence 
of inducer followed by lysis and reaction with enzyme substrates resulting in the formation of a visual 
sign (fluorescence or colour) that allows for the identification of clones producing improved enzymes40. 
Another common screening method is based in cultivation of the library, disruption and enzyme assays 
in microtiter plates40. Screening methods based on agar or microtiter plates assays only allow to explore 
a relatively small population of mutants (106) which is some orders of magnitude smaller than the library 
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size59. More recently, fluorescence-activated cell sorting (FACS) has appeared as a high sensitivity 
technique of high-throughput screening that allows to analyse a large number of variants (108 per day) 
of a library, with single cell resolution60. In a FACS sorter, cells enter in single droplet form and are 
illuminated with the use of a focused laser beam. Then, fluorescence of individual cells is measured and 
a charge is applied to the cells of interest that with the application of an electrostatic field leads to its 
deflection into a collection tube59. The use of fusion reporter proteins provides a very useful tool for 
single-cell fluorescence analysis and can be used in directed evolution approaches to eliminate inactive 
variants that present destabilizing mutations59. It is possible to couple the activity of a target enzyme to 
the co-overproduction of a fluorescent protein such as green fluorescent protein (GFP) allowing the set-
up of a high-throughput screening of enzyme activities coupled to a FACS system41. As the sequence 
space of proteins is very large, it is almost impossible to explore all mutations that could occur in a 
protein, which can be considered the major drawback of the directed evolution strategy43.  
1.6 Context of the project 
The research focus of the Microbial and Enzyme Technology Lab at ITQB has been to explore enzymes 
with potential to be used in the areas of health, environmental and industrial biotechnology. The set-up 
of biocatalytic processes for best performance depends on the development and combination of 
multidisciplinary research strategies at the biocatalyst level: i) selection of an enzyme with industrial 
interest, ii) biochemical characterization for providing structural, catalytic and stability fingerprints, iii) 
engineering to improve their performance and robustness and iv) application to the synthesis, 
degradation or modification of compounds of interest. The research activities are at the interface of 
protein science and protein technology, and have focused on the isolation, characterization and 
engineering of useful bacterial oxidoreductases (laccases, metalloxidases, azoreductases and more 
recently DyP type peroxidases). 
The major aim of this work was to set-up a directed evolution approach to improve the catalytic efficiency 
of AsP2Ox for D-glucose and dioxygen, with the final purpose of replacing GOx in a large range of 
industrial and analytic applications. Firstly, we tested the co-production in E. coli cells of recombinant 
AsP2Ox with the Hyper protein (from hydrogen peroxide), a specific fluorescent probe that detect H2O2 
inside living cells61, in order to develop a fast and reliable in vivo AsP2Ox activity screening method that 
would allow to discriminate between clones that contain active and inactive AsP2Ox based on the 
fluorescence of recombinant whole cells62. Secondly, several strategies were followed to increase the 
amounts of soluble AsP2Ox in E. coli cells and facilitate the detection of AsP2Ox oxidase activity in cell 
crude extracts: overproduction of AsP2Ox in various E.coli strains, cultivation of cells at different 
temperatures and culture media, and co-production of AsP2Ox and different chaperones in recombinant 
cells. Thirdly, the best conditions for mutagenesis and screening of AsP2Ox mutants were identified 
after optimization and validation of directed evolution protocols at the level of cell growth, lysis and 
enzymatic assays, in 96 well-plates and in Petri dishes. Finally, a library of 25 000 variants was created 
by epPCR and screened using a colorimetric high-throughput ‘activity-on-plate’ assay to detect 
improved variants of AsP2Ox in the oxidation of D-glucose in the presence of oxygen. A hit 2C9 variant 
containing 3 mutations was identified and through the complementary use of site-directed mutagenesis 
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and biochemical characterization of enzyme variants it was possible to unveil the critical role of acquired 
mutations from the catalytic and structural viewpoints and select the best candidate for a second 
generation of evolution.  
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2. Material and Methods 
2.1 Bacterial strains, plasmids and media 
E. coli strain DH5α (Novagen) was used for routine propagation and amplification of plasmid constructs. 
E. coli Tuner (DE3, Novagen), KRX (Promega) and BL21 star (DE3, Novagen) strains were used to 
express the genes coding for wild-type AsP2Ox and mutants cloned in pET-15b plasmid (Novagen), the 
plasmids containing the chaperone genes tested (table 2.1) and the Hyper gene cloned in pET-28b 
(Novagen). In BL21 star and Tuner strains the target genes are under the control of the T7 promoter, 
induced by isopropyl β-D-1-thiogalactopyranoside (IPTG), and in the KRX strain the genes are under 
the control of rhaPBAD promoter, induced by rhamnose. Luria-Bertani medium (LB) and Terrific Broth 
medium (TB) were used for the maintenance and growth of E. coli strains, supplemented with 
appropriated antibiotics. LB medium contains (per liter): 10 g of tryptone, 5 g of yeast extract and 10 g 
of NaCl. TB medium contains the following components (per liter): 12 g of tryptone, 24 g of yeast extract, 
4 mL of glycerol (86%), 2.3 g of KH2PO4 and 12.5 g of K2HPO4. Super Optimal Growth medium (SOB) 
was used for the growth of electrocompetent cells. SOB medium contains (per liter): 20 g of tryptone, 5 
g of yeast extract, 0.584 g of NaCl and 0.186 g of KCl. All culture media were sterilized in an autoclave 
at 121ºC and stored at room temperature until use. 
2.2 Preparation of E. coli electrocompetent cells 
An LB agar plate was streaked out with a frozen stock of E. coli cells and incubated overnight at 37⁰C. 
A single colony was picked to inoculate 20 mL of SOB medium and the culture was incubated overnight 
at 37⁰C, 180 rpm. Growth in 500 mL of SOB medium was started at an optical density at 600 nm 
(OD600nm) of 0.05 and incubated at 37⁰C, 180 rpm. After 2.5 h (OD600nm ≃ 0.8), cells were transferred to 
ice-cold centrifuge bottles and spun down (5,000 rpm, 15 min at 4⁰C). The supernatant was discarded, 
and the cell pellets were washed with 250 mL of a sterile ice-cold 10% glycerol solution. The cells were 
centrifuged, re-washed in 250 mL of the same solution, centrifuged for a third time and re-suspended in 
500 μL of the same solution. Aliquots of 150 μL were frozen in liquid nitrogen and stored at -80⁰C. 
For the co-expression of two recombinant genes in the same E. coli strain, first the E.coli cells were 
transformed with the plasmid harbouring the gene encoding for one of the proteins and with the resulting 
colonies, electrocompetent cells were prepared as previously described. Afterwards, the second 
plasmid was transformed into these electrocompetent cells so that the co-expression of genes coding 
for both recombinant proteins is possible. 
2.3 Transformation of E. coli cells 
One microliter of purified plasmids or five microliters of ligation mixtures were added to an aliquot of 150 
μL electrocompetent cells (previously thawed on ice) mixed and placed on ice for 5 min. This mixture 
was transferred to a sterile and ice-cold electroporation cuvette, which was placed in the Xcell ShockPod 
chamber (Gene Pulser XcellTM, Biorad) and pulsed using set conditions of C = 25 μF, PC = 200 Ω, V 
= 2.5 kV. Immediately afterwards, 1 mL of LB medium was added; the suspension was transferred to 
an Eppendorf and incubated at 37⁰C for 1 h, 180 rpm. The cells were diluted (to obtain single colonies) 
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and were spread to an LB agar plate supplemented with appropriate antibiotic and incubated at 37⁰C 
overnight. 
2.4 Heterologous expression of target genes 
2.4.1 Cell growth of E. coli strains overexpressing recombinant genes  
2.4.1.1 Overproduction of AsP2Ox at different temperatures 
The plasmid pSM-1 (containing the wild-type asP2Ox gene) was transformed into E. coli BL21 star cells 
and afterwards the obtained single colonies were used to inoculate 10 mL of LB medium supplemented 
with 100 µg/mL ampicillin and the cells were grown overnight at 37°C, 180 rpm. Fresh cultures were 
transferred to two Erlenmeyer flasks containing 20 mL of LB medium supplemented with 100 µg/mL 
ampicillin, in order to start the growth with an OD600nm  0.05. Cultures were incubated at 37°C, 180 rpm 
and when OD600nm ≃ 0.6, 100 µM IPTG was added to the cultures and the temperature was decreased 
to 25°C in one culture and to 10°C in the other culture. In the following day, cells were collected by 
centrifugation (8,000 rpm, 10 min at 4°C). 
2.4.1.2 Co-production of AsP2Ox in the presence of chaperones 
From a fresh agar plate, individual E. coli colonies with pSM-1 plasmid and individual colonies presenting 
both pSM-1 and one of each plasmid present in table 2.1 were picked and transferred to 96-well plates 
(Sarstedt) containing 200 μL of LB medium supplemented with 100 μg/mL ampicillin (cells containing 
the pSM-1 plasmid) and with 100 μg/mL ampicillin and 20 μg/mL chloramphenicol (cells containing the 
additional plasmids). In order to avoid evaporation only the interior wells were used while the peripheral 
wells were filled with water and plates were sealed with a foil. Cultures were grown for 24 h at 37⁰C, 750 
rpm in a Titramax 1000 shaker (Heidolph). Twenty microliters were used to inoculate 180 μL of TB 
medium supplemented with antibiotics in 96-well plates that were incubated at 37⁰C, 750 rpm. After 2.5 
h of incubation, induction of genes coding for the chaperones (table 2.1) was performed by adding 0.5 
mg/mL L-arabinose and/or 5 ng/mL tetracycline, and after more 1 h of incubation, 100 µM IPTG was 
added to all cultures for the induction of the gene coding for AsP2Ox. The growth proceeded at RT for 
a 24 h period after which cells were harvested by centrifugation (4,000 rpm, 30 min at 4⁰C). 
For scaling-up, individual E. coli colonies harbouring both pSM-1 and pG-KJE8 plasmids from a fresh 
agar plate were used to inoculate 20 mL of LB medium supplemented with 100 µg/mL ampicillin and 20 
μg/mL chloramphenicol and growth proceeded overnight at 37°C, 180 rpm. Cultures were transferred 
to two Erlenmeyer flasks containing 100 mL of LB medium supplemented with 100 µg/mL ampicillin and 
20 μg/mL chloramphenicol, in order to start growth with an initial OD600nm  0.05. Cultures were 
incubated at 37°C, 180 rpm and when OD600nm ≃ 0.4, 0.5 mg/mL L-arabinose and 5 ng/mL tetracycline 
were added and the temperature was decreased to 25°C. When OD600nm ≃ 0.6, 100 µM IPTG was added 
to both cultures. In the next day, cells were collected by centrifugation (8,000 rpm, 10 min at 4°C). 
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Table 2.1 Plasmid harbouring the wild-type asP2Ox gene and plasmids containing genes for the different 
chaperones that were used in the co-expression using the BL21 star strain. 
 
 
2.4.1.3 Co-production of AsP2Ox with Hyper 
The plasmid pSM-1 containing the asP2Ox gene was transformed into E.coli BL21 star, Tuner and KRX 
strains that were previously transformed with the Hyper-containing plasmid. Single colonies were used 
to inoculate 10 mL of LB medium supplemented with 100 µg/mL ampicillin (for cells with pSM-1 plasmid 
only), with 10 µg/mL kanamycin (for cells with Hyper-containing plasmid only) and 100 µg/mL ampicillin 
plus 10 μg/mL kanamycin (for cells harbouring both the pSM-1 and Hyper-containing plasmids). Cells 
were grown overnight at 37°C, 180 rpm. These cultures were used to inoculate 20 mL of LB medium 
supplemented with appropriated antibiotics at a starting OD600nm = 0.05. Cultures were incubated at 
37°C, 180 rpm, and when OD600nm ≃ 0.6, 100 µM IPTG was added to recombinant E. coli BL21 star and 
Tuner strains, and 0.2 % rhamnose to recombinant E. coli KRX and the temperature was decreased to 
25°C.  
2.4.2 Cell disruption  
For cultures grown in 96-well plates, a chemical cell disruption method was employed: cell pellets were 
suspended in 100 μL of 40% Bacterial Protein Extraction Reagent (B-PER®) lysis solution (Thermo 
Scientific). After this, plates were centrifuged (4,000 rpm, 30 min at 4⁰C) and the supernatant collected 
(crude extracts). 
For cultures grown at larger scales, the cell pellets were suspended in 20 mM Tris-HCl buffer at pH 7.6 
containing 5 mM MgCl2, 10 μg/mL DNase I and 5 μg/mL of a mixture of protease inhibitors (antipain 
and leupeptin). The cell suspensions were disrupted in a French press (Thermo IEC) operating at 900 
psi in a process repeated 3 times, allowing for the complete cellular rupture. The lysates were then 
centrifuged (13,000 rpm, 1 h at 4°C) to separate the non-soluble fraction (i.e. the pellet corresponding 
to cell debris) from the soluble fraction (crude cell extracts in the supernatant). 
Plasmids Proteins Promotor Inductor Resistance Reference 
pSM-1 AsP2Ox T7 IPTG Ampicilin 3 
pGro7 GroES-GroEL araB L-Arabinose Chloramphenicol 
Takara Bio 
Inc 
pG-Tf2 GroES-GroEL-Tf Pzt-1 Tetracycline Chloramphenicol 
Takara Bio 
Inc 
pG-KJE8 
DnaK-DnaJ-GrpE 
GroES-GroEL 
araB 
Pzt-1 
L-Arabinose 
Tetracycline 
Chloramphenicol 
Takara Bio 
Inc 
pKJE7 DnaK-DnaJ-GrpE araB L-Arabinose Chloramphenicol 
Takara Bio 
Inc 
pTf16 Tf araB L-Arabinose Chloramphenicol 
Takara Bio 
Inc 
pMJS9 Erv1p-PDI araB L-Arabinose Chloramphenicol 63 
pFH255 Erv1p-DsbC araB L-Arabinose Chloramphenicol 63 
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2.4.3 Determination of protein concentration 
Protein concentration was determined using the Bradford assay with bovine serum albumin (BSA) as 
standard64. A calibration curve was performed with known concentrations of BSA: 0 - 0.6 mg/mL and  
20 μL of sample was added to 1 mL or 180 μl (96-well-plate) of Bradford reagent (100 mg of Comassie 
Blue G dissolved in 45% of ethanol, 100 mL orthophosphoric acid and 750 mL of distilled water, for 1 L 
of solution), mixed and 10 min later, the absorbance was measured at 595 nm in a spectrophotometer 
Novaspec III (Amersham Biosciences) or in a Synergy 2 (BioTek) micro plate reader. The protein 
measurements were performed in triplicate. 
2.4.4 SDS-PAGE analysis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), a method for separating 
proteins based on the difference of their molecular weight, was utilized to monitor the recombinant 
protein production as well as the level of protein purification.  The running gel was prepared as follows: 
12.5% (v/v) acrylamide, “Lower Tris buffer” (375 mM Tris-HCl, 0.1% SDS, pH 8.8), 0.1% (w/v) SDS, 
0.1% (w/v) ammonium persulfate (APS), 0.06% (v/v) N, N, N’, N’-tetramethylethylenediamine (TEMED). 
For the stacking gel: 5% (v/v) acrylamide, “Upper Tris buffer” (125 mM Tris-HCl, 0.1% SDS, pH 6.8), 
0.1% (w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED. The electrophoresis was performed at 220 V 
during 45 min in the “Electrophoresis Buffer” (192 mM glycine, 25 mM Tris, 0.1% SDS, pH 8.3). Before 
the application of the protein samples (10 μg of total protein in each well for crude extracts and 1 μg of 
purified protein) these were mixed with 2 × “Sample Preparation Solution” (2% SDS, 6.255 mM TrisHCl 
pH 6.8, 5% 2-mercaptoethanol, 0.5 mM DTT, 5% glycerol, and 0.025% bromophenol blue) and 
denatured at 99°C for 10 min. Gels were stained with Coomassie® blue staining solution (50% ethanol, 
10% acetic acid, 0.05% (v/v) Coomassie brilliant blue R-250) with a slow agitation for homogeneous 
staining. Destaining was performed by using a solution of 10% ethanol and 10% acetic acid. 
2.4.5 Enzymatic assays 
The activity of AsP2Ox was measured using a horseradish peroxidase (HRP) coupled assay in which 
the hydrogen peroxide generated by AsP2Ox reaction is used as substrate by the HRP enzyme 
(Panreac AppliChem) to oxidise two molecules of 2,2'-Azinobis(3-ethylbenzthiazoline-6-sulfonic acid) 
(ABTS) generating the radical form of ABTS (green) that could be easily monitored at 420 nm (ε = 36,000 
M-1 cm-1)65. Reactions were performed at 37ºC in a Nicolet Evolution 300 spectrophotometer from 
Thermo Industries (Madison). The initial activity in crude cell extracts was measured by adding the 
enzymatic mixture of 100 mM sodium phosphate buffer at pH 6.5 containing 100 mM of D-glucose, 1 
mM ABTS and 10 U HRP. One Unit of P2Ox activity was defined as the amount of enzyme that is 
necessary for the consumption of 2 μmol of ABTS per min, which equals the consumption of 1 μmol of 
O2 per min. 
2.5 Fluorescence Microscopy  
Cells co-producing heterologous Hyper and AsP2Ox proteins were grown overnight and in the following 
day 500 μl of each culture was centrifuged (6,000 rpm, 2 min). The cell pellet was suspended in 
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phosphate-buffered saline (PBS) buffer at pH 7.4 and the cellular suspension was observed in a 
fluorescence microscope DM6000B (Leica). The images were edited using the MetaMorph® Microscopy 
Automation & Image Analysis Software. The remaining volume of cell culture was centrifuged (4,000 
rpm, 30 min at 4ºC), the pellet was suspended in disruption buffer and disrupted using a French-press 
as described above and the crude extracts were analysed in terms of protein content by the Bradford 
method and SDS-PAGE. 
2.6 Directed evolution  
2.6.1 Random mutagenesis by error-prone PCR (epPCR) 
Mutations in the asP2Ox gene were generated by using error-prone PCR (epPCR). P2OxFwd (5’ 
CAGGAACTGGTGGCGGGCATATGAGCGGTCACCGGTATCC3’) and P2OxRev (5’ 
GCGCTACCGGCTCGAGTTCATTATTTAGACAGTCTATTG 3’) flanking the gene beyond the NdeI and 
XhoI sites, were used for amplification. The epPCR was carried out in a 50 μL reaction containing 3 ng 
of DNA template, 1 μM of primers, 200 μM of dNTPs, 1.5 mM MgCl2, Taq polymerase buffer, variable 
concentrations of MnCl2 (0.01-0.50 mM) to assess the mutation rate, and 2.5 U of Taq polymerase 
(Thermo Scientific). After an initial denaturation period of 2 min at 95⁰C, the following steps were 
repeated for 30 cycles in a thermal cycler (MyCyclerTM thermocycler, Biorad): 1 min at 95⁰C, 1 min at 
63⁰C and 1 min at 72⁰C and at the end 10 min at 72⁰C. The amplified product (5 μL) was visualized 
using agarose (1%) electrophoresis in a 40 min-run under an electrical field of 100 V. Afterwards, 10 U 
of DpnI (Thermo Scientific) were added and the suspension was incubated at 37⁰C for 5 h. The final 
products were purified using the GFX PCR DNA and the Gel Band Purification kit (GE Healthcare) and 
eluted with mili-Q water. Ten microliters of purified PCR product and 10 μL of pET-15b vector (Novagen) 
were digested with 10 U of NdeI (Thermo Scientific) and 20 U of XhoI (Thermo Scientific) at 37⁰C for 2 
h. The vector pET-15b was simultaneously dephosphorylated with 1 U of alkaline phosphatase (FastAP, 
Thermo Scientific), to prevent plasmid self-ligation. The products were purified using the GFX PCR DNA 
and the Gel Band Purification kit (GE Healthcare). The ligations were performed with 0.5 U of T4 DNA 
ligase (Thermo Scientific) using a 1:3 ratio of vector to insert with 60 ng of vector after a DNA 
quantification in nanodropTM 2000c (Thermo scientific). This mixture was incubated overnight at room 
temperature and then purified using the GFX PCR DNA and the Gel Band Purification kit (GE 
Healthcare). Transformation into E.coli BL21 star was performed as described above. 
2.6.2 Overexpression of AsP2Ox and variants in 96-well plates 
Individual colonies were picked from a fresh agar plate, and transferred to a 96-well standard plate 
(Sarstedt) containing 200 μL of LB medium supplemented with 100 μg/mL ampicillin. As previously 
mentioned, to avoid evaporation only the interior wells were used while peripheral wells were filled with 
water and the plates were sealed with a foil. Four wells in each plate were used to inoculate the parent 
of each generation (wild-type was the parent of the first generation). Cultures were grown for 24 h at 
37⁰C, 750 rpm in a Titramax 1000 shaker (Heidolph). Twenty microliter aliquots were used to inoculate 
180 μL of TB medium supplemented with 100 μg/mL ampicillin in 96-well standard plate that was 
incubated at 37⁰C, 750 rpm. After 4 h of incubation, 0.2% rhamnose was added to induce gene 
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expression in KRX cells and 100 µM IPTG to induce gene expression in BL21 star cells. The growth 
proceeded at RT for a 24 h period. The cells were harvested by centrifugation (4,000 rpm, 30 min at 
4⁰C). 
2.6.3 Cell disruption in 96 well plates 
Four different methods were tested for cell disruption. In the first method, an enzymatic approach was 
performed where cell pellets in 96-well plates were suspended in 100 μL of 20 mM Tris-HCl buffer at pH 
7.6 supplemented with 2 mg/mL of lysozyme. In the second method, cell pellets were submerged in 
liquid nitrogen and then thawed at room temperature for 5 min. After 3 cycles of freeze and thaw, cell 
pellets were suspended in 100 μL of 20 mM Tris-HCl buffer at pH 7.6. In the third method, cell pellets 
were incubated at 80°C for 15 min and then thawed at 37ºC for 5 min. After 3 cycles of freeze and thaw, 
cell pellets were suspended in 100 µL of 20 mM Tris-HCl buffer at pH 7.6. In the fourth method, a 
chemical disruption was tested where 100 μL of 40% Bacterial Protein Extraction Reagent (B-PER®) 
lysis solution (Thermo Scientific) were used to suspend the cell pellets, that were incubated for 15 min 
at RT with slow agitation. After cell disruption, the suspensions were centrifuged (4,000 rpm, 30 min at 
4⁰C), the supernatants collected (cell crude extracts) and used for enzymatic activity measurements.  
2.6.4 Spectrophotometric high-throughput activity screening using D-glucose and 1,4-
BQ as substrates 
Fifty microliters of crude cell extracts were transferred to a new 96-well plate and initial activity (Ai) was 
measured after adding 150 μL of 100 mM sodium phosphate buffer at pH 6.5 containing 10 mM of D-
glucose and 1 mM of 1,4-BQ. The absorbance change was followed on a Synergy 2 (BioTek) micro 
plate reader at 290 nm (ε = 2.24 mM−1cm−1). The activity of each variant in relation to the parent enzyme 
was calculated using the ratio of the initial activity of the variant (v) to the parent (p) (Aiv/Aip). The variants 
exhibiting the highest activities were selected and re-screened, to rule out false positives. The selected 
hit variants from the first generation were grown overnight in 10 mL LB medium supplement with 100 
μg/mL ampicillin, at 37⁰C, 180 rpm. The plasmid DNA was extracted by using GeneJET Plasmid 
Miniprep Kit (Thermo Scientific) and mutations identified by DNA sequencing analysis. To identify the 
codon exchanges and amino acid substitutions, the SnapGene® software was used.  
2.6.5 ‘Activity-on-plate’ high-throughput screening using D-glucose and O2 as 
substrates 
This procedure was based in the lab previous experience in directed evolution “activity-on-plate” 
screenings66. No activity could be detected using E. coli KRX cells overproducing pSM-1 (where 
asP2Ox-wild-type was cloned) with this method and consequently all validation was performed using 
cells of E. coli BL21 star transformed with pSM-1 and later with mutant plasmid libraries. After 
transformation, cells were properly diluted in order to reach a maximum of 200 colonies per plate of solid 
LB medium supplemented with 100 µg/mL ampicillin and 10 µM IPTG where grown overnight. Colonies 
were replica-plated onto chromatography paper (Whatman) and the original culture-plate was re-
incubated at 37°C until colonies appeared (~ 5 h). The colonies on the filter papers were lysed by 
carefully soaking the chromatography paper in a solution of 40% Bacterial Protein Extraction Reagent 
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(B-PER®) lysis solution (Thermo Scientific) because through the enzymatic disruption using lysozyme 
no activity was observed. The filter papers were then transferred to Petri dishes and dried for 
approximately 30 minutes at RT. Then the filter papers were soaked in a reaction solution containing 
100 mM sodium phosphate buffer at pH 6.5, 10 mM D-glucose, ABTS (1–20 mM) and 10 U HRP, and 
incubated at RT until a green-purple colour appears (after approximately 2h). The variants showing 
increased enzymatic activities were identified by the dark purple colour. 
2.6.6 Activity re-screening using glucose and O2 as substrates 
All variants showing increased enzymatic activities in the ‘activity-on-plate’ high-throughput screening 
were grown in 96-deep well plates (Greiner Bio-One) similar to 96-well standard plates but with 1 mL-
volume of culture instead of 0.2 mL-volume and their activity was measured using the HRP coupled 
assay. The enzymatic assays with 50 μl of crude extracts of variants in a total volume of 200 μl were 
performed in 100 mM sodium phosphate buffer at pH 6.5 in the presence of 100 mM D-glucose, 10 U 
HRP and 10 mM ABTS at 37ºC using a Synergy2 microplate reader (BioTek) and rates were calculated 
based in absorbance differences at 420 nm (ε = 36,000 M-1 cm-1). The plasmid DNA of positive clones 
was extracted by using GeneJET Plasmid Miniprep Kit (Thermo Scientific) and mutations identified by 
DNA sequencing analysis. To identify the codon exchanges and amino acid substitutions, the 
SnapGene® software was used. The parent for the next generation was chosen based in the highest 
initial activity achieved among the various variants. 
2.7 Site-directed mutagenesis 
Single and double amino acid substitutions in the asP2Ox gene were created using the Quick Change 
mutagenesis protocol (Stratagene). The plasmid pSM-1 (containing the asP2Ox-wild-type gene) was 
used as DNA template with appropriated primers (table 2.2) and the plasmid obtained after the insertion 
of the F300V mutation was used as template to insert A35T mutation to produce the double mutant. 
PCRs were performed in a thermal cycler (MyCyclerTM Thermal Cycler, Biorad) in 50 µL reaction 
volumes containing 3 ng of DNA template, 1 µM of primers, 200 µM of dNTPs (NZYTech), NZYProof 
polymerase buffer, and 1.3 U of NZYProof polymerase (NZYTech). The conditions used for performing 
the PCR reactions are listed in table 2.3. The amplified product was digested with 10 U of DpnI (Thermo 
Scientific) at 37⁰C for 5 h to eliminate the wild-type template and visualized through an agarose (1%) 
gel in a 40 min-run under an electrical field of 100 V. The resulting product was purified using GFX PCR 
DNA and Gel Band Purification kit (GE Healthcare) and used to transform electrocompetent E. coli DH5-
α cells. The presence of the desired mutation(s) in the resulting plasmid and the absence of additional 
mutations in other regions of the insert were confirmed by DNA sequencing. 
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Table 2.2 Primers used in the site-directed mutagenesis for the construction of different mutants. Fwd-primer 
forward; Rev-primer reverse. The nucleotides in bold and underlined correspond to the base substitutions. 
 
Mutation Primer 
A35T 
Fwd 5’-GGAAGCCCCCGGTACCACGATCGCGATGTTCGAAGTGG-3’ 
Rev 5’-CCACTTCGAACATCGCGATCGTGGTACCGGGGGCTTCC-3’ 
F300V 
Fwd 5’-CCTGAACGACCAGGCGCAGGTGGTGGTCGCGAGCAGGC-3’ 
Rev 5’-GCCTGCTCGCGACCACCACCTGCGCCTGGTCGTTCAGG-3’ 
 
Table 2.3 Conditions used in the PCR reactions for the construction of different mutant enzymes using site-directed 
mutagenesis.      
                             
Mutant Denaturation Cycles 
Number 
of cycles 
Final amplification 
A35T 4 min at 95ºC 
95°C : 1 min 
70°C: 1.5 min 
72°C: 10 min 
22 10 min at 72°C 
F300V 4 min at 95ºC 
95°C : 1 min 
72°C: 1.5 min 
72°C: 10 min 
25 10 min at 72°C 
A35T/F300V 4 min at 95ºC 
95°C : 1 min 
70°C: 1.5 min 
72°C: 10 min 
22 10 min at 72°C 
 
2.8 Production and purification of wild-type and recombinant AsP2Ox variants 
For the production of wild-type AsP2Ox and variants at a larger scale, single colonies were used to 
inoculate 50 mL of LB medium supplemented with 100 μg/mL ampicillin, which were grown overnight at 
37⁰C, 180 rpm. These cultures were used to inoculate 1 L of LB medium in 5L-Erlenmeyer flasks, 
supplemented with 100 μg/mL ampicillin, in order to start the growth with an OD600nm = 0.05. Cultures 
were incubated at 37⁰C at 180 rpm and when OD600nm ≃ 0.6, 100 μM IPTG was added. After 24 h of 
cultivation, cells were collected by centrifugation (8,000 rpm, 15 min at 4⁰C) and the cellular pellets were 
re-suspended in the same conditions mentioned above and were disrupted in a French press (Thermo 
IEC) operating at 1000 psi in a process repeated 5 times, allowing for the complete cellular rupture. Cell 
debris was removed by centrifugation (18,000 rpm, 2h at 4⁰C) and crude extracts were filtrated with a 
0.2 μm membrane to remove large particles in suspension prior to loading onto the chromatographic 
column. The protein purification was performed in an ÄKTA purifier (GE Healthcare). The crude extract 
was loaded onto a 1 mL HisTrap HP column (GE Healthcare) equilibrated with 20 mM Tris-HCl buffer 
at pH 7.6 supplemented with 0.2 M NaCl and 10 mM imidazole. Elution was carried with a 0-100% 
gradient of imidazole (1 M) with a flow rate of 1 mL/min. The yellow fractions were collected, desalted 
using a PD-10 desalting column (GE Healthcare), concentrated in 20 mM Tris-HCl buffer at pH 7.6 with 
0.2 M NaCl and stored in buffer with 20% of glycerol at −20⁰C. 
    
19 
 
2.9 Spectroscopic analysis of FAD-ligation 
UV–Visible absorption spectra of the purified enzyme were recorded at room temperature by using a 
Nicolet Evolution 300 spectrophotometer from Thermo Industries (Waltham). For identification of the 
flavin cofactor, a preparation of purified AsP2Ox was treated with 0.4% (w/v) of SDS and the UV–Vis 
spectrum was recorded67. Alternatively, 5% trichloroacetic acid was added to a purified protein 
preparation and heated at 100ºC for 10 min. After centrifugation (13,000 rpm, 10 min) a UV-Vis spectrum 
was recorded. 
2.10 Kinetic analysis 
The enzymatic activity of purified wild-type AsP2Ox and mutants proteins was monitored using a Nicolet 
Evolution 300 spectrophotometer (Thermo Industries) and a Synergy2 microplate reader (BioTek) where 
the formation of product was monitored at 420 nm (ε = 36,000 M-1 cm-1). All enzymatic assays were 
performed at least in triplicate. The routine reaction mixture contained 1 mM ABTS, 10 U HRP, 1 M D-
glucose and was saturated with pure oxygen prior to initiation with enzyme. One unit of AsP2Ox activity 
was defined as the amount of enzyme necessary for the oxidation of 2 μmol of ABTS (equivalent to the 
oxidation of 1 μmol of D-glucose) per min under the assay conditions. 
All steady-state kinetic measurements were performed at 37ºC in 100 mM sodium phosphate buffer at 
pH 6.5. Apparent steady-state kinetic parameters (kcat and Km) were measured for D-glucose in oxygen-
saturated solutions using the routine ABTS-peroxidase assay. Kinetic data were fit directly into the 
Michaelis-Menten equation (Origin-Lab software).  
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3. Results and Discussion 
3.1 Development of an in vivo activity screening for AsP2Ox  
In order to develop an activity screening that would avoid time consuming cell disruption procedures 
and enzymatic activity assays, the co-production of AsP2Ox and Hyper protein, a specific fluorescent 
probe that detect H2O2 inside living cells was tested (figure 3.1). This probe consists of a circularly 
permuted yellow fluorescent protein (cpYFP) inserted into the regulatory domain of a prokaryotic H2O2-
sensing protein (OxyR) which demonstrates submicromolar affinity to H2O2 and insensitivity to other 
oxidants61. The Hyper protein has a cysteine residue that reacts with H2O2, leading to the formation of 
a disulfide bond, that results in a conformational alteration, and subsequent change in the excitation 
spectrum62. The fluorescent signals of Hyper show two excitation peaks at 420 and 500 nm that upon 
exposure to hydrogen peroxide result in a proportional decrease of the excitation band at 420 nm and 
an increase of the band at 500 nm61. The utilization of this system based on the fluorescent properties 
of Hyper would allow to easily eliminating inactive mutants in a library of variants62.  
Figure 3.1 Hyper-based screening for in vivo detection of enzymatic H2O2 production. The objective was to identify 
better variants of AsP2Ox through a higher production of H2O2 that would result in an increased excitation spectrum 
of Hyper at 500 nm and a decrease at 420 nm. The reduced spectrum is shown as a solid line and the oxidized 
spectrum as a dashed line. Adapted from62. 
 
With this objective, AsP2Ox and Hyper were co-produced in BL21 star cells, the strain previously known 
to result in the highest production of both proteins. Different cells were grown: cells producing only 
AsP2Ox, cells producing only the Hyper protein and cells co-producing both AsP2Ox and Hyper 
proteins. After cultivation, cells were visualized using a fluorescence microscope (figure 3.2). As 
expected, no fluorescence was present in cells where only AsP2Ox is produced. In cells producing only 
the Hyper protein, it was possible to observe a drastic change in the fluorescence and also in the shape 
and dimensions of cells: they become much larger when compared with cells only producing AsP2Ox 
and intracellular inclusion bodies are visible. The higher fluorescence intensity observed is most 
probably due to H2O2 present in the cytoplasm of cells, originated from the cellular oxidative stress, that 
is also visible in non-induced cells probably due to a leakage in the expression of the Hyper gene in the 
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absence of inducer. Even though cells that produce both AsP2Ox and Hyper proteins showed a slight 
higher dimension and fluorescence, there are no sufficient differences as compared with cells that only 
produce the Hyper protein that could allow the implementation of a FACS-based screening system 
(figure 3.2). The cell crude extracts of the above mentioned cultures were analysed by SDS-PAGE 
(figure 3.3) where it is possible to observe that both proteins were overproduced in induced cultures.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Images of induced and non-induced cell cultures obtained by bright-field and fluorescence microscopy 
producing AsP2Ox, Hyper and co-producing both proteins in the BL21 star strain. When only AsP2Ox was 
produced, no fluorescence was detected as expected. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 SDS-PAGE of BL21 star crude extracts. (M) Marker, non-induced (1) and induced (2) cell extracts 
overproducing AsP2Ox, induced (3) and non-induced (4) cell extracts overproducing Hyper and, induced (5) and 
non-induced (6) cell extracts overproducing both AsP2Ox and Hyper proteins. The arrows show the bands that 
correspond to the AsP2Ox protein (64 kDa) and to the Hyper protein (66 kDa). 
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In an attempt to find a strain that allows better differentiate the fluorescence intensity between cells 
producing only Hyper and cells co-producing both Hyper and AsP2Ox proteins, two additional 
recombinant E.coli strains were tested: KRX and Tuner strains (figure 3.4). No fluorescence was 
detected in Tuner cells, indicating that the Hyper protein is not produced by this strain. With KRX cells, 
a low fluorescence intensity was detected with no major differences when only Hyper or both AsP2Ox 
and Hyper proteins were produced, even though the dimensions, shape and fluorescence of cells were 
not so dramatically changed as observed when BL21 star cells were used. These results were confirmed 
by the SDS-PAGE analysis where the protein bands that correspond to AsP2Ox and Hyper proteins 
were barely observed (figure 3.5). 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Images of cell cultures obtained by bright-field and fluorescence microscopy producing Hyper and co-
producing both proteins (AsP2Ox and Hyper) in KRX and Tuner strains. No fluorescence was detected when Tuner 
strain was used as expression strain. 
 
 
 
 
 
 
 
 
 
Figure 3.5 SDS-PAGE of KRX and Tuner crude extracts. (M)-Marker, (1) KRX cell extracts overproducing Hyper, 
(2) KRX cell extracts overproducing Hyper and AsP2Ox, (3) Tuner cell extracts overproducing Hyper and (4) Tuner 
cell extracts overproducing AsP2Ox and Hyper. AsP2Ox has a molecular weight of 64 kDa and Hyper of 66 kDa 
approximately. 
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In conclusion, the Tuner strain is not suitable for the production of both proteins due to the lack of 
expression of the correspondent genes. On the other hand, the use of BL21 star or KRX cells for the 
co-production of both Hyper and AsP2Ox proteins is not suitable for a FACS-based activity screening 
of AsP2Ox due to the high “auto”-fluorescence of Hyper in the absence of AsP2Ox enzyme production. 
These results showed that there is a high amount of H2O2 inside the cells, possibly resulting from cellular 
oxidative stress that can oxidise the Hyper protein, thus preventing the identification of improved 
AsP2Ox variants.  
3.2. Optimization of growth conditions to increase the solubility of recombinant 
AsP2Ox in E. coli cells 
A large amount of recombinant AsP2Ox overproduced in E. coli cells is present in the insoluble fraction, 
most likely in the form of inclusion bodies (figure 3.6). Inclusion bodies result from the intracellular 
accumulation of partially folded produced proteins that aggregate through hydrophobic or ionic 
interactions or a combination of both in the cytoplasm of E. coli 14. The relatively low amounts of soluble 
AsP2Ox enzyme in crude extracts of E. coli, associated with the very low detected specific activity of 
purified enzyme for molecular oxygen (kcat/Km = 0.03 M-1s-1) resulted in the absence of detected activity 
for AsP2Ox using O2 as electron acceptor in crude cell extracts of E. coli. This fact prevents the 
development of an appropriate activity screening strategy using as substrates D-glucose and O2 in the 
process of directed evolution. 
 
  
 
 
 
 
 
 
 
 
Figure 3.6 SDS-PAGE performed with the insoluble and soluble fractions of recombinant E. coli cell extracts of 
cells overproducing AsP2Ox. (M) marker, (1) insoluble fraction and (2) soluble fraction. The arrow shows the band 
that corresponds to the AsP2Ox protein (64 kDa). 
 
With the aim of increasing the soluble production of AsP2Ox enzyme, the temperature of the growth 
cultures was reduced from 37 to 25 and 10ºC after induction with IPTG. A decrease in temperature  is 
expected to result in a decrease of bacterial growth rate and in an increase of soluble protein content14. 
It was possible to visualize in the SDS-PAGE (figure 3.7) that a higher amount of AsP2Ox protein was 
achieved in the soluble fraction upon incubation at 25ºC after IPTG induction as compared with 10ºC. 
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In spite of the absence of activity using O2 as electron acceptor in both crude extracts, in further studies, 
the temperature of growth was shifted from 37 to 25ºC after IPTG induction. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 SDS-PAGE of insoluble and soluble fractions of cells grown at different temperatures after IPTG 
induction. (M) marker, insoluble (1) and soluble fraction (2) of crude extracts of cells incubated at 10ºC after IPTG 
induction and insoluble (3) and soluble fractions (4) of crude extracts of cells incubated at 25ºC after IPTG induction. 
The arrow indicates the band that corresponds to AsP2Ox (~64 kDa). 
 
As an alternative strategy for the prevention of inclusion body formation, the co-production of AsP2Ox 
protein in the presence of recombinant molecular chaperones was performed. In our laboratory there 
are seven plasmids encoding for different chaperones (table 3.1) and all were co-produced with AsP2Ox 
in E. coli cells cultivated in 96-well plates. As observed in Table 3.1, very high coefficients of variation 
(CV = standard deviation/mean x 100 %) both in the values of the final OD600nm of cultures and protein 
concentration in crude extracts were observed. Importantly, when activity was tested using D-glucose 
and O2 as electron acceptor, only the reaction mixtures using crude extracts of cells co-producing 
AsP2Ox and DnaK-DnaJ-GrpE-GroES-GroEL chaperones (pG-KJE8 plasmid) showed a very tenuous 
green colour, characteristic of the cation radical ABTS+ formation, and indicative of enzyme reaction 
activity. Based in this result a larger scale (100 mL) culture using this co-production system was 
performed.  
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Table 3.1 Final OD600nm of cell cultures co-producing AsP2Ox and different chaperones and protein concentration 
in cell crude extracts. 
 
 
Two cultures co-producing AsP2Ox and selected chaperones (pG-KJE8 plasmid) were performed: one 
where the chaperones were induced and a second where the chaperones were not induced. In the SDS-
PAGE the production of chaperones with 22, 40, 60 and 70 kDa is visible in fractions of crude extracts 
of induced as compared with those from non-induced cells (figure 3.8).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 SDS-PAGE of insoluble and soluble fractions of induced and non-induced cells overproducing AsP2Ox 
and chaperones. (M) marker, soluble fractions of crude extracts where genes coding for chaperones were induced 
(1) and non-induced (2), insoluble fractions of crude extracts of cells where genes coding for chaperones were 
induced (3) and non-induced (4). Black arrows correspond to chaperone proteins: GrpE, DnaJ, GroEL and DnaK 
that present molecular weights of 22, 40, 60 and 70 kDa respectively. 
 
The above mentioned results are supported by the 6-fold higher protein concentration in crude extracts 
of induced (5.8 ± 0.5 mg/mL) as compared with non-induced cells (1.0 ± 0.1 mg/mL). It was not possible 
to assess in the SDS-PAGE (figure 3.8) the putative increased production of AsP2Ox in soluble fractions 
Plasmids Chaperones Molecular weight (kDa) OD600nm CV (%) 
Protein 
(mg/mL) 
CV (%) 
pGro7 GroES-GroEL 10; 60 0.7 ± 0.5 71 0.4 ± 0.2 50 
pG-Tf2 GroES-GroEL-Tf 10; 60; 56 0.5 ± 0.4 80 0.2 ± 0.2 100 
pG-KJE8 
DnaK-DnaJ-GrpE 
GroES-GroEL 
70; 40; 22; 
10; 60 
0.3 ± 0.2 67 0.2 ± 0.2 100 
pKJE7 DnaK-DnaJ-GrpE 70; 40; 22 0.3 ± 0.3 100 0.2 ± 0.2 100 
pTf16 Tf 56 0.6 ± 0.4 67 0.4 ± 0.2 50 
pMJS9 Erv1p-PDI 32; 56.7 0.6 ± 0.4 67 0.3 ± 0.1 33 
pFH255 Erv1p-DsbC 32; 47.2 0.5 ± 0.4 80 0.3 ± 0.2 67 
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of crude extracts of cells where the chaperones were induced due to the fact that both GroEL and DnaK 
chaperones have a molecular weight (60 ; 70 kDa) very close to AsP2Ox (64 kDa). However, when 
enzymatic activity was tested in crude extracts, no improvement was detected indicating that the 
presence of chaperones apparently did not result in an increased production of soluble AsP2Ox as 
desired. 
3.3 Directed Evolution of AsP2Ox  
3.3.1 Validation of high-throughput screenings in 96-well plates 
As previously mentioned, the most crucial step of directed evolution is to set-up procedures that allow 
identifying the desired mutants minimizing the selection of false positives. For this, several experiments 
need to be performed in order to develop, validate and implement methods at the level of cell growth, 
protein production, cell lysis and activity screening assays in 96-well plates68.  
3.3.2 Selection of the best conditions to overexpress asP2Ox in E.coli 
The E. coli strain that leads to a higher production of AsP2Ox was previously known to be the BL21 star. 
In this work the capabilities of the E. coli KRX strain for the overproduction of AsP2Ox were tested since 
this strain acts as a cloning as well as an expression strain, which would avoid additional steps of 
plasmid transfer among strains in the evolution process. With this aim, both strains BL21 star and KRX 
were grown in 96-well microplates in two different growth media: LB and TB, in order to choose the 
conditions that result in minimal variations in the growth and production of the enzyme of interest. After 
cell lysis with B-PER® solution and centrifugation, protein concentration and specific activity using 1,4-
BQ as electron acceptor was monitored in crude extracts. The substrate used was 1,4-BQ because with 
O2 no activity can be observed in crude extracts (table 3.2). 
Table 3.2 Final OD600nm of cell cultures of BL21 star and KRX strains grown in different media, protein concentration 
and specific activity in crude cell extracts. Enzymatic assays were performed at 37⁰C, in 100 mM sodium phosphate 
buffer at pH 6.5 in the presence of 10 mM D-glucose and 1 mM 1,4-benzoquinone. 
 
 
The obtained results show that lower coefficients of variation were achieved with BL21 star as compared 
to the KRX strain in all steps of the screening process. Moreover, no major CV differences were 
observed in protein content and enzyme activities in crude extracts of BL21 star cells grown in LB or TB 
media. Therefore BL21 star grown in TB medium was chosen for further experiments since a higher 
concentration of protein is present in crude extracts, a lower CV was obtained for specific activity and a 
Strain  OD600nm CV (%) [Protein] (mg/mL) CV (%) 
Specific Activity 
(nmol/min.mg) 
CV (%) 
BL21 star 
LB 1.0 ± 0.3 30 0.4 ± 0.1 25 24 ± 9 38 
TB 1.2 ± 0.4 33 0.6 ± 0.2 33 22 ± 8 36 
KRX 
LB 0.7 ± 0.3 43 0.3 ± 0.1 33 102 ± 127 125 
TB 1.2 ± 0.6 50 0.5 ± 0.3 60 86 ± 106 123 
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stronger yellow colour (characteristic of flavin proteins) was visible in crude extracts, an indication of 
higher amounts of AsP2Ox in solution. 
3.3.3 Selection of the cell disruption method in 96-well plates 
After selecting the E.coli strain and cultivation medium for the screening process the most appropriate 
cell disruption method was identified. Four methods of cell disruption were tested (table 3.3). The first 
was an enzymatic method that uses lysozyme, an enzyme that catalyzes the hydrolysis of β (1→4) 
linkages between the N-acetylmuraminic acid and the N-acetyl-D-glucosamine residues in the 
peptidoglycan of bacterial cell walls. The utilization of this method resulted in a high coefficient of 
variation in the specific activity. 
The low-temperature physical methods putatively result in the formation of small pores in the bacterial 
membrane/wall that allow soluble overproduced proteins to be released without causing total destruction 
of the cells69. In the first method tested, cells were submitted to three cycles of freezing with liquid 
nitrogen following by thawing at room temperature and, in the second method tested, cells were 
subjected to three cycles of freezing at - 80⁰C for 15 min and then thawing at 37⁰C for 5 minutes. By 
following these methods, the concentration of total protein was ~6 times lower and the specific activity 
5-fold higher when compared to the enzymatic method (table 3.3). This result may indicate that the 
passage of intracellular proteins through the pores of cellular walls to the outer space somehow benefit 
the passage of AsP2Ox. However, the coefficients of variation using both physical methods were 
considered too high for an accurate screening of variant libraries.  
Finally, a fast chemical method was tested, the commercial B-PER® solution containing a non-ionic 
detergent. The application of this solution resulted in a concentration of protein 2-fold lower and 3-fold 
higher compared to those achieved with the enzymatic and the physical methods, respectively, while 
the specific activities are similar and ~3 times lower to that observed with enzymatic and the physical 
methods, respectively (table 3.3). However, the lowest coefficients of variation both in terms of protein 
concentration and specific activity were achieved, putatively leading to a lower probability of finding false 
positive clones during the evolution process of AsP2Ox, and this method was therefore chosen for 
further experiments. 
Table 3.3 Protein concentration and specific activity in crude extracts after using different disruption methods. Cells 
were disrupted using enzymatic (lysozyme 2 mg/mL), physical (freeze/thaw using Liquid Nitrogen (LN)) or 
freeze/thaw through incubation at -80⁰C) and chemical (B-PER® lysis solution) methods. 
 
 
Disruption Method  [Protein] (mg/mL) CV (%) 
Specific Activity 
(nmol/min.mg) 
CV (%) 
Enzymatic 
Lysozyme 
2 mg/mL 
1.1 ± 0.4 36 13 ± 12 92 
Physical 
Freeze/Thaw 
(LN2) 
0.2 ± 0.1 50 64 ± 46 72 
Freeze/Thaw 
(-80⁰C) 
0.2 ± 0.1 50 44 ± 25 56 
Chemical B-PER 0.6 ± 0.2 33 22 ± 8 36 
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3.3.4 Generation of AsP2Ox mutant libraries using epPCR 
In general, the finest strategy in directed evolution is to obtain libraries of mutants that present a low 
number of mutations because this eliminates the possible accumulation of neutral or deleterious 
mutations, since increased mutation rates are proportional to a decreased number of functional protein 
variants51. In general, a mutation rate of ~1-3 nucleotides per gene correspond to a library with 30-40% 
of mutants having less than 10% of the parent enzyme’s activity (‘dead’ mutants) and this is considered 
the appropriate rate for directed evolution strategies51. 
The variation of manganese chloride (MnCl2) concentration in the PCR reaction, is one of the parameters 
that allows to adjust the mutation rate in the gene of interest51. With this objective, six libraries were 
constructed with increasing concentrations of MnCl2 (0.01-0.5 mM) to test which concentration led to 
the desired mutation rate of ~1-3 nucleotides in the asP2Ox gene. The enzymatic activities of 54 clones 
of each library were tested in 96 well-plates (1 plate per library) and compared to the wild-type AsP2Ox 
(figure 3.9).  As expected, the number of “dead” mutants increased with the manganese chloride 
concentration in the PCR reaction. In the presence of 0.01 mM and 0.10 mM MnCl2 all clones showed 
an activity higher than 10% of the parent enzyme’s activity while using 0.20, 0.30, 0.40 and 0.50 mM 
MnCl2, 2%, 9%, 13% and 37% of inactive clones were observed, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Landscape correspondent to six variant libraries using different MnCl2 concentrations: 0.01 mM (∆), 0.10 
mM (○), 0.20 mM (♦), 0.30 mM (●), 0.40 mM (▲) and 0.50 mM (x). Activity of clones relative to the wild-type is 
plotted in descending order. 
 
Based on these results, the concentration of MnCl2 chosen for random mutagenesis in the directed 
evolution procedure of AsP2Ox enzyme was 0.5 mM because it would hypothetically allow to obtain the 
desired rate of mutation corresponding to ~1-3 base substitutions51 in the asP2Ox gene. 
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3.3.5 High-throughput activity screening of the mutant library using 1,4-BQ as electron 
acceptor 
The catalytic efficiency of purified AsP2Ox for D-glucose using oxygen as electron acceptor is 4 orders 
of magnitude lower when compared with 1,4-BQ. Consequently, no activity using oxygen as electron 
acceptor was detected in crude cells extracts growing in standard 96-well plates in any condition tested 
(table 3.2 and 3.3). For this reason, it was decided to screen the first generation of evolution using 1,4-
BQ as substrate. 
A total of 2 052 clones were screened (figure 3.10-A). Owing to the relative high coefficient of variation 
in the specific activity measured for the wild-type enzyme (36%), all clones that presented an activity 
2.5 times higher as compared with the wild-type parent (66 clones) were re-screened in order to 
decrease the number of false positives (figure 3.10-B). After the re-screening, three clones 19C11, 
26C11 and 14B3 that have shown specific activities 4, 3 and 3 times higher than the parent, respectively, 
were selected, plasmids were extracted, transformed on DH5-α cloning strain, purified and sent to 
sequencing. 
 
Figure 3.10 Directed evolution landscape corresponding to the first generation of mutants. (A) Activity relative to 
wild-type of 2052 clones screened in the first generation. (B) Re-screening of the best 66 variants found in the first 
generation. Enzymatic assays were performed at 37⁰C, in 100 mM sodium phosphate buffer at pH 6.5 in the 
presence of 10 mM D-glucose and 1 mM 1,4-benzoquinone. 
 
The sequencing results have unfortunately shown that genes from the variants were wild-type asP2Ox, 
representing false positive clones. New epPCR were performed followed by digestion with DpnI to 
eliminate wild-type plasmid, and DNA from five random clones from each library was purified and 
sequenced. The results showed that using 0.5 mM MnCl2 in the PCR reaction, resulted in 12 
substitutions per gene, and that the concentration of MnCl2 that produced the desired rate of 1-3 base 
substitutions per gene was around 0.01 mM (table 3.4). These results were surprising considering the 
previous experience in the laboratory and the data in the literature. However, it was decided to generate 
a new library of mutants by epPCR in the presence of 0.01 mM MnCl2. 
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Table 3.4 Average of base substitutions in the asP2Ox gene after epPCR performed in the presence of different 
concentrations of manganese chloride. Four to five clones were randomly selected from libraries generated after 
epPCR at different MnCl2 concentrations, plasmids were extracted, transformed on DH5-α cloning strain, purified 
and sent to sequencing. 
 
 
 
 
 
 
 
 
 
 
3.3.4. “Activity-on-plate” high-throughput activity screening using O2 as electron 
acceptor 
To test the new library of variants it was decided to try a different strategy: an ‘activity-on-plate’ 
screening, a colorimetric assay developed and validated using BL21 star overproducing wild-type 
AsP2Ox. This qualitative strategy allows for the screening of a higher number of variants in a shorter 
period of time when compared to the 96-well plate activity screening since it eliminates the step of 
picking individual colonies from agar plates and growing cells in liquid medium. Moreover and 
importantly, it allows identifying variants of AsP2Ox with higher oxidative activity since the lysed colonies 
are tested for the oxidation of D-glucose in the presence of oxygen by following a coupled assay with 
HRP in the presence of ABTS. The differences observed in the colour of lysed colonies are the result of 
the ABTS oxidation. For this screening, colonies present on the solid media, resultant from growth of 
BL21 star cells transformed with the mutant library in the presence of IPTG, were transferred to a 
Whatman chromatography paper and soaked in a solution of B-PER® 40%. Next, the paper containing 
the lysed colonies is soaked in enzymatic reaction mixture containing D-glucose, HRP and ABTS and 
improved variants are identified through the darker colour presented (figure 3.11). 
 
 
 
 
 
 
 
[MnCl2] (mM) Base substitutions average 
0.01 1 
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0.30 16 
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0.50 12 
    
32 
 
 
 
 
Figure 3.11 Overview of ‘activity-on-plate’ screening used for the directed evolution of AsP2Ox enzyme. 
 
When the colonies were grown on agar medium in the absence of inducer (IPTG), as expected, no 
activity was observed (figure 3.12-A). Immediately after soaking the disrupted cells grown in the 
presence of IPTG in the reaction mixture with 20 mM ABTS (figure 3.12-B), a strong green colour 
appeared that quickly changed to a dark purple. These two colours are due to the existence of two 
relatively stable and electrochemically reversible oxidation states of ABTS: the cation radical ABTS•+ 
(green) and the dication ABTS2+ (dark purple)70. Considering that at the conditions tested an intense 
purple colour was observed, the concentration of ABTS was decreased from 20 to 1 mM (figure 3.12-
C-E) and with this later concentration, it was seen just a weak purple colour that appeared 2 hours after 
the filters had been soaked in the reactional mixture.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 ‘Activity-on-plate’ high-throughput assay (with 10 U HRP and 10 mM D-glucose) using BL21 star cells 
transformed with wild-type AsP2Ox plasmid and grown in LA media in the presence of 10 μM IPTG. (A) Non-induced 
cells incubated in the presence of 20 mM ABTS. Cells  overexpressing asP2Ox gene in the presence of (B) 20 mM, 
(C) 10 mM, (D) 5 mM and (E) 1 mM of ABTS, respectively. 
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Using the ‘activity-on-plate’ high-throughput assay screening a mutant library of 25,000 variants was 
screened (figure 3.13). All clones that presented higher activity than wild-type (153 variants), as 
measured by the intensity of the purple colour in the Whatman paper, were selected for rescreening 
(figure 3.14). Seven variants were chosen and a new round of rescreening was performed (figure 3.15). 
A large variation in activity was observed among colonies of the same variant and as a consequence, 
the rescreening of the best seven mutants was performed in 96-deep well plates. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 ‘Activity-on-plate’ high-throughput assay (10 U HRP, 1 mM ABTS and 10 mM D-glucose) using BL21 
star cells expressing (A) wild-type asP2Ox gene and (B-D) mutant library constructed using epPCR in the presence 
of 0.01 mM  MnCl2. Colonies within circles represent variants with improved activity visible by the darker colour. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 Rescreening using the same conditions than previously used of the best 153 variants through ‘activity-
on-plate’. The seven clones showing a faster and stronger purple colour than wild-type were chosen for a new 
rescreening. Colonies within circles represent variants with improved activity and inside rectangles are represented 
colonies overexpressing wild-type asP2Ox. 
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Figure 3.15 Rescreening of the best seven variants through ‘activity-on-plate’. The wild-type AsP2Ox and variants 
have shown different growth rates and consequently very weak or inexistence activity. 
 
Growing the cells harbouring the wild-type asP2Ox gene in 96-deep well plates led to similar values of 
final OD600nm (1.3 ± 0.3) with a lower coefficient of variation as compared with the standard 96 well-
plates (23% in 96 deep well-plates and 33% in standard 96 well-plates) and approximately 4-times 
higher total protein concentration (2.2 mg/mL ± 0.1) with a lower coefficient of variation (5% in 96-deep 
well plates and 33% in standard 96 well-plates). Consequently, the seven variants were grown in 96-
deep well plates and only the 2C9 variant showed a very weak green colour comparing with control 
(figure 3.16) and a specific activity of 0.7 nmol/min.mg was measured. 
 
 
 
 
 
 
 
Figure 3.16 Enzymatic activity using crude extracts of wild-type AsP2Ox and 2C9 in the presence of 100 mM D-
glucose, 10 U HRP and 1 mM ABTS in 100 mM sodium phosphate buffer at pH 6.5. In the control reaction no crude 
extract was added. 
 
Based on these results, 2C9 plasmid was extracted, transformed on DH5-α cloning strain, purified and 
sent to sequencing. The results showed that 2C9 has three nucleotide alterations that led to two amino 
acid substitutions and a silent mutation (A35T, F300V and Q343Q). In order to evaluate the performance 
of the 2C9 hit and to compare with wild-type AsP2Ox, it was decided to first characterize the enzyme 
before going forward to a second generation of evolution. 
1B4 
 1C4 
 2E4 
 2C9 
 
2E11 
 2F10 
 3C9 
 
wild-type 
 
Control 
 
Wild-type 
 
2C9 
 
    
35 
 
3.4. Kinetic and biochemical characterization of the hit 2C9 variant 
3.4.1 Structural analysis of mutations that improved the activity of 2C9 
As previously mentioned, the 2C9 hit accumulated two non-synonymous (A35T and F300V) and one 
synonymous mutation (Q343Q). Through the analyses of a model structure of AsP2Ox constructed 
based on the crystal structure of pyranose 2-oxidase from P. chrysosporium (PDB code: 4MIG) provided 
by Prof Willem van Berkel (figure 3.17), it is possible to observe that the mutation A35T is located in a 
loop that belongs to the Rossmann domain of FAD-binding subdomain. This mutation is located about 
20 Å from the FAD cofactor and the catalytic residues His440 and Asn482. In T. multicolor and 
Peniophora sp., a tyrosine residue is present in the correspondent position unlike P. chrysosporium that 
presents a leucine amino acid residue. The other amino acid substitution present in 2C9 is F300V that 
is located in a β-sheet of the substrate-binding domain and is about 15 Å from the FAD cofactor and the 
catalytic residues His440 and Asn482 (figure 3.17). A phenylalanine, that is an aromatic and 
hydrophobic residue, was substituted by the smaller valine (hydrophobic) amino acid. In T. multicolor, 
Peniophora sp., and P. chrysosporium, a cysteine which is a hydrophilic residue is present in the 
corresponding position. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Model structure of wild-type AsP2Ox where the FAD cofactor is represented in yellow sticks. A35 is in 
red, F300 in green and Q343 in blue colour. The distances from A35, F300V and Q343 to the FAD cofactor are 
represented in blue in Ångström (Å). 
 
3.4.2 Spectroscopic analysis and identification of FAD ligation 
After the production and purification of the protein 2C9 in the same conditions of wild-type AsP2Ox, it 
was possible to observe that despite the similar final OD600nm of cell cultures (3.9 and 4.4 for wild-type 
and 2C9, respectively), the concentration of purified protein was 3-fold lower for 2C9 when compared 
with wild-type AsP2Ox (20 and 6 mg protein per L of LB media, respectively; figure 3.18). 
A35 
F300 
Q343 
 15 Å to FAD 
 10 Å to FAD 
 20 Å to FAD 
    
36 
 
 
 
 
 
 
 
 
 
Figure 3.18 SDS-PAGE of BL21 star crude extracts overproducing wild-type and 2C9 purified proteins. (M) Marker, 
(1) crude extracts of cells overproducing wild-type AsP2Ox protein, (2) AsP2Ox after purification using a metal 
affinity chromatography, (3) crude extracts of cells overproducing 2C9 variant protein and (4) 2C9 after purification 
using a metal affinity chromatography. The arrow indicates the band that corresponds to AsP2Ox proteins (~64 
kDa). 
 
The UV-Vis absorption spectra of two different eluted purified fractions from the metal affinity 
chromatography column were recorded and compared with the UV-Vis absorption spectrum of wild-type 
AsP2Ox (figure 3.19-A). Despite the purified 2C9 fractions showing the characteristic yellow colour of 
flavins, the UV-Vis absorption spectrum of one of the fractions just presented one band with absorbance 
maximum at 405 nm that corresponds to fully-reduced neutral flavin FADH2 (dashed line) while the UV-
Vis spectrum of the second fraction, in addition to the 405 nm band presented an additional absorbance 
peak at 340 nm that corresponds to fully-reduced anionic flavin FADH- (dotted line)71,72. It is possible to 
conclude that performing cell disruption and purification of the hit 2C9 in the presence of light, led to the 
photoreduction of FAD cofactor which consequently become inactive. These results demonstrate a 
higher sensitivity of 2C9 to light inactivation as compared to the wild-type enzyme. Therefore, cell 
disruption and purification of the variant enzyme was performed in the total absence of light and a UV-
Vis absorption spectrum of the purified enzyme was recorded (figure 3.19-B). When 2C9 was purified 
in dark conditions, the UV-Vis absorption spectrum of AsP2Ox exhibited the two typical absorbance 
maxima at 390 and 460 nm. The treatment of the enzyme with 5% TCA resulted in a colourless pellet 
and a yellow supernatant displaying the characteristic FAD absorbance spectrum, and indicating that 
the flavin cofactor is not covalently bonded to the 2C9 enzyme similarly to the wild-type enzyme as 
assessed by a down-shift of both absorbance maxima to 380 and 450 nm after protein denaturation67 
(dotted line). However, no activity could be measured using this purified protein most likely due to 
photoreduction and inactivation during the procedures to measure enzymatic activity.   
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Figure 3.19 (A) UV-vis spectra of AsP2Ox as isolated (solid line) and of 2C9 fractions after purification (dashed 
and dotted lines) (B) UV-vis spectra of purified 2C9 as isolated (solid line) and after treatment with 0.4% (w/v) SDS 
or 5%TCA followed by heating and centrifugation (dotted line). 
 
3.5 Site-directed mutagenesis 
In order to identify the role of mutations on the enzyme variant properties, including the lower production 
yields and the photo inactivation of the FAD cofactor, responsible for the absence of activity in purified 
2C9, three variant enzymes were constructed using site-directed mutagenesis: A35T, F300V and the 
double variant 2C9* (A35T/F300V). The five proteins (wild-type, 2C9, 2C9*, A35T and F300V) were first 
overproduced in a small scale culture of 100 mL to analyse their differences in protein production. The 
SDS-PAGE showed that crude extracts of variant proteins presented lower production yields than wild-
type (figure 3.20). However, the production of 2C9 is significantly increased when the silent mutation 
was removed (2C9*). Despite synonymous mutations do not affect the identity of the encoded amino 
acid, each organism has a preference for a set of codons over others (codon bias) and its different 
utilization can directly affect the protein expression levels and regulation and the protein folding73. The 
silent mutation present in the 2C9 hit (Q343Q) leads to around half of tRNA gene copy numbers in E.coli 
when compared with the wild-type nucleotide73 and is at least partially responsible for the lower 
expression of 2C9 when compared with the wild-type enzyme.   
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Figure 3.20 SDS-PAGE of BL21 star crude extracts overproducing wild-type and mutant proteins. (M) Marker, crude 
extracts overproducing (1) wild-type, (2) 2C9, (3) 2C9*, (4) A35T and (5) F300V proteins. The arrow indicates the 
band that corresponds to AsP2Ox proteins (~64 kDa). 
 
Large scale cultures (1L) of BL21 star overproducing wild-type, 2C9*, A35T and F300V proteins were 
performed with the objective of purifying and characterizing the variants. The results confirmed the 
higher protein yields in wild-type and A35T proteins as compared to 2C9* and F300V variants (table 
3.5). Therefore, it was possible to conclude that both the silent Q343Q and F300V mutations are 
responsible for the lower expression of 2C9* by E.coli cells. The 2C9* variant without the silent mutation 
had a production yield 2-fold higher when compared with the 2C9 variant. Furthermore, 2C9* (without 
the silent mutation) showed 3-fold higher specific activity. Interestingly, both single variants showed 
lower activity than 2C9* showing that the activity of this variant is dependent on the simultaneous 
presence of both mutations (table 3.5).  
Table 3.5 Total protein concentration achieved from 1L of culture of Bl21 star cells producing wild-type, 2C9, 2C9*, 
A35T and F300V proteins determined after purification using a metal affinity chromatography and specific activity 
achieved after enzymatic assays at 37⁰C, in 100 mM sodium phosphate buffer at pH 6.5 in the presence of 1 M D-
glucose, 1 mM ABTS and 10 U HRP.  
 
 
 
 
 
 
 
 
AsP2Ox protein [Protein]total (mg) 
Specific Activity 
(nmol/min.mg) 
Wild-type 39 ± 1.8 1.5 ± 0.03 
2C9 6 ± 0.4 - 
2C9* 12 ± 1.4 4.8 ± 0.34 
A35T 32 ± 1.0 1.1 ± 0.03 
F300V 12 ± 0.4 2.4 ± 0.10 
3 4 
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After purification in the presence of light and confirmation of the purity of the proteins through a SDS-
PAGE (data not shown), UV-Vis absorption spectra were recorded before and after treatment with 0.4% 
(w/v) SDS where it was possible to observe that variants 2C9*, A35T and F300V presented the typical 
UV-vis absorption spectra, with two absorbance maxima at 390 and 460 nm, and that the FAD cofactor 
is non-covalently associated (figure 3.21). These results showed that the silent mutation Q343Q, present 
in 2C9 hit close to the FAD cofactor (ca. 10Å-figure 3.17), is the responsible for the photo-inactivation 
behaviour of 2C9 hit variant. Silent single nucleotide polymorphisms have been assumed to have no 
effect on gene function or phenotype due to the inexistence of amino acid change of the protein product. 
However, in recent studies it was verified that synonymous codon substitutions can alter the translation 
kinetics of a determined mRNA due to the fact that infrequent codons in mRNA appear to be slowly 
translated, whereas frequent codons are rapidly translated with consequences in the protein folding that 
can result in different conformations and functions, for example, an altered substrate specificity74,75 or 
as in the present case, a likely conformation that results in the spontaneous formation of reduced FAD 
intermediates in the presence of light. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 UV-vis spectra of (A) 2C9*, (B) A35T and (C) F300V as isolated (solid line) and after treatment with 
0.4% (w/v) SDS (dotted line). 
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Steady-state kinetic analyses were performed with wild-type and variant enzymes using D-glucose and 
O2 (figure 3.22). The A35T enzyme presents a similar relation of specific activity vs. substrate 
concentration to the wild-type and obtained data could be fitted using the Michaelis-Menten equation. 
However, for 2C9* and F300V enzymes it was evident that enzyme rates achieved a maximum at 
approximately 1 M of D-glucose and after that concentration decline as the substrate concentration 
increased. The sharp decrease in rates impaired fitting the data to a substrate inhibition curve. 
Therefore, only the data up to 1.2 M was considered and fit using the Michaelis-Menten equation. The 
apparent steady-state kinetic parameters in table 3.6 shows that the hit 2C9* presents a 3-fold higher 
enhanced efficiency (kcat/Km) to the wild-type enzyme. Moreover, it is also possible to observe that 
apparently A35T is a neutral mutation, with similar kcat and Km to wild type, while F300V is a functional 
mutation that becomes more beneficial when combined with A35T, considering that 2C9* exhibited a 
higher kcat/Km than the single F300V variant (table 3.6), a phenomenon designated by positive 
epistasis76. Nevertheless the catalytic efficiency of 2C9* is still six orders of magnitude lower when 
compared with P2Ox characterized from fungal origins11,12 and multiple rounds of directed evolution are 
needed to improve its efficiency.  
 
Figure 3.22 Apparent steady-state kinetic analysis of (A) wild-type, (B) 2C9*, (C) A35T and (D) F300V proteins for 
D-glucose using O2 as electron acceptor. Reactions were performed in 100 mM sodium phosphate buffer at pH 6.5, 
using O2 saturated solutions at 37°C, and the ABTS-peroxidase assay. The kinetic parameters were fitted directly 
using the Michaelis-Menten equation (Origin-Lab software). 
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Table 3.6 Apparent steady-state kinetic parameters of AsP2Ox (wild-type and variants) determined using D-glucose 
and O2. Enzymatic assays were performed at 37⁰C, in 100 mM sodium phosphate buffer at pH 6.5 in the presence 
of 1 M D-glucose, 1 mM ABTS and 10 U HRP. 
 
 
 
 
 
 
 
Overall results show that the most appropriate candidate to be used as parent in the second generation 
of directed evolution is 2C9* since the elimination of the silent mutation improved the stability as well as 
the production of the enzyme as compared to variant 2C9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein Km (M) Vmax (nmol/min.mg) kcat (s-1) kcat/Km (M-1s-1) 
Wild-type 0.7 ± 0.04 2.2 ± 0.4 0.002 ± 0.0002 0.003 ± 0.001 
2C9* 0.5 ± 0.06 6.0 ± 1.6 0.005 ± 0.001 0.010 ± 0.01 
A35T 0.7 ± 0.14 2.3 ± 0.4 0.002 ± 0.0003 0.003 ± 0 
F300V 0.4 ± 0.04 3.4 ± 0.3 0.003 ± 0.0003 0.007 ± 0 
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4. Conclusions 
This work was targeted at improving the kinetic properties of AsP2Ox through protein engineering. The 
development of an effective and simple strategy of evolution that allowed finding and identifying 
improved variants from a library of thousands of mutants was performed. In spite of the difficulties 
encountered in all steps of validation of the directed evolution approach it was possible to develop a 
solid strategy through the use of epPCR at a low concentration of MnCl2 (0.01 mM) and an ’activity-on-
plate’ screening based on a coupled HRP-ABTS colorimetric assay. The implementation of the validated 
strategy allowed testing a high number of variants (25 000) with an appropriate mutation rate (1-3 
nucleotide base substitutions per gene) to an increased oxidase activity in a short period of time. The 
hit variant (2C9) was identified after the first generation of evolution, showing three mutations located at 
the surface of the protein. The utilization of a complementary strategy of site-directed mutagenesis 
unveiled the effect of each mutation present in the variant enzyme and allowed to select the best 
candidate to be used in the second generation of directed evolution.  
In the future, the Microbial and Enzyme Technology laboratory is particularly interested in establishing 
collaborations for the application of improved AsP2Ox variants in biosensors to control the sugar levels 
in patients with diabetes through the use of cellulose fiber paper. It is also a purpose to study the 
structure-function relationship determinants for the activity and stability of AsP2Ox, contributing with 
new fundamental knowledge on P2Oxs features and contributing to answer the long-standing question 
in protein science of “how function and structure are related”. Considering, this goal two collaborations 
were established, with the group of Prof Willem van Berkel (Wageningen University), a worldwide 
reference in the field of flavoproteins and with Dr. Carlos Frazão, head of the Structural Biology 
laboratory at ITQB, an experienced crystallographer with a high publication track record, to determine 
the crystal structure of wild-type AsP2Ox which hopefully will be followed by the determination of the 
structure of variant enzymes found in the course of evolution. Finally, we aim at investigating the 
molecular mechanisms of enzyme fitness evolution, a critical knowledge for engineering new proteins, 
metabolic pathways and organisms for biotechnological applications. 
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